Retrospective Register for Uveal Melanoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorMedical University of Vienna

About this trial

Background: Uveal melanoma (UM) is a common primary ocular malignancy associated with limited overall survival in the advanced stage of the disease. Fundamental breakthrough regarding the management of the disease and the overall-survival have not yet been achieved. Studies with large cohorts are difficult to perform due to limited patient numbers, therefore retrospective analyses are of great potential to gain further knowledge in a disease with high clinical needs.

Aim: The proposed project is a register for patients with UM treated at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021.

Patients and Methods: Patients treated for UM at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021 will be included in the register. Information on the baseline characteristics, survival times and course of the disease will be gathered via retrospective chart review and saved in a password-secured database.

Eligibility criteria

Qualifiers

Patients 18 - 99 years

Diagnosis of uveal melanoma

Disqualifiers

Patients younger than 18 years of age

Inadequate or missing information on the clinical course in patient charts

Trial design

Treatments tested in this trial

  • any therapy suitable

Treatment groups

1,400 Participants
are divided into 1 treatment group

Sponsors and collaborators